The research we do today impacts our community tomorrow. Our investigators—leaders in state-of-the-art scientific exploration—excel in the fields of diabetes and endocrinology, reproductive medicine, healthcare analytics and oncology. We specialize in translational research, taking results from the laboratory bench to the patient bedside. Partner with us as we search for answers to the healthcare issues facing our community and the world.
Institutes, Centers & Departments
- Center for Integrative Neuroscience and Inflammatory Diseases (CINID)
- Department of Medicine
- Emergency Medicine
- Fetal Cardiovascular Center
- Glennan Center for Geriatrics and Gerontology
- Hearing and Balance Center/Audiology
- Leroy T. Canoles Jr. Cancer Research Center
- Microbiology and Molecular Cell Biology
- National Center for Collaboration in Medical Modeling and Simulation (NCCMMS)
- Obstetrics and Gynecology: Clinical Research Center
- Obstetrics and Gynecology
- Otolaryngology (ENT)
- Pediatrics
- Physiological Sciences
- Psychiatry and Behavioral Sciences
- Research and Infrastructure Service Enterprise
- Sentara Center for Healthcare Simulation and Immersive Learning
- Strelitz Diabetes Center
Meet our Faculty
Dr. Nyalwidhe focuses on the application of proteomics, glycomics and mass spectrometry in the field of cancer biology and general biomarker discovery. Dr. Nyalwidhe is a founding member of the Leroy T. Canoles Jr. Cancer Research Center and Director George L. Wright Jr. Center for Biomedical Proteomics.
Dr. Sanford, Professor of Pathology and Anatomy, is a highly regarded expert on the neurophysiology of sleep and stress. His primary research focuses on the brain mechanisms linking sleep, stress and learning in anxiety and posttraumatic stress disorder. Dr. Sanford has been awarded over $5 million in funding from the National Institutes of Health since 2007. He was an Associate Editor of the medical journal “SLEEP” from 2006 to 2016.
Dr. Galkina, Associate Professor of Microbiology & Molecular Cell Biology, has studied immune responses in atherosclerosis and type 2 diabetes. She received $1.76 million from the NIH’s National Heart, Lung and Blood Institute to study how atherosclerotic conditions affect immune cell functions. She is a member of the American Heart Association’s Women’s Leadership Committee and an AHA fellow. She works with the NHLBI Vascular Cell and Molecular Biology Study Section, which reviews NIH grant applications.
Dr. Forgacs-Lonart, Associate Professor of Physiological Sciences, has completed extensive research on myosin, a motor protein that helps muscles move, and has received grants from the NIH and the American Heart Association. She is investigating how cardiomyopathy mutations alter the ATPase enzyme mechanism and how different pharmacological agents affect the chemomechanical cycle. She has worked at EVMS since 2001 and has served as a postdoctoral fellow with the AHA.
Dr. Semmes, the Anthem Distinguished Professor for Cancer Research, Associate Dean for Translational Research and Professor of Microbiology and Molecular Cell Biology, has led the Leroy T. Canoles Jr. Cancer Research Center as its director since 2009. With nearly $900,000 in funding from the NIH’s National Cancer Institute, Dr. Semmes’ team identified a for detecting advanced prostate cancer in urine samples. He is an editorial board member for “Cancer Research,” a journal of the American Association for Cancer Research.
Dr. Nyalwidhe focuses on the application of proteomics, glycomics and mass spectrometry in the field of cancer biology and general biomarker discovery. Dr. Nyalwidhe is a founding member of the Leroy T. Canoles Jr. Cancer Research Center and Director George L. Wright Jr. Center for Biomedical Proteomics.
Dr. Sanford, Professor of Pathology and Anatomy, is a highly regarded expert on the neurophysiology of sleep and stress. His primary research focuses on the brain mechanisms linking sleep, stress and learning in anxiety and posttraumatic stress disorder. Dr. Sanford has been awarded over $5 million in funding from the National Institutes of Health since 2007. He was an Associate Editor of the medical journal “SLEEP” from 2006 to 2016.
Dr. Galkina, Associate Professor of Microbiology & Molecular Cell Biology, has studied immune responses in atherosclerosis and type 2 diabetes. She received $1.76 million from the NIH’s National Heart, Lung and Blood Institute to study how atherosclerotic conditions affect immune cell functions. She is a member of the American Heart Association’s Women’s Leadership Committee and an AHA fellow. She works with the NHLBI Vascular Cell and Molecular Biology Study Section, which reviews NIH grant applications.
Dr. Forgacs-Lonart, Associate Professor of Physiological Sciences, has completed extensive research on myosin, a motor protein that helps muscles move, and has received grants from the NIH and the American Heart Association. She is investigating how cardiomyopathy mutations alter the ATPase enzyme mechanism and how different pharmacological agents affect the chemomechanical cycle. She has worked at EVMS since 2001 and has served as a postdoctoral fellow with the AHA.
Dr. Semmes, the Anthem Distinguished Professor for Cancer Research, Associate Dean for Translational Research and Professor of Microbiology and Molecular Cell Biology, has led the Leroy T. Canoles Jr. Cancer Research Center as its director since 2009. With nearly $900,000 in funding from the NIH’s National Cancer Institute, Dr. Semmes’ team identified a for detecting advanced prostate cancer in urine samples. He is an editorial board member for “Cancer Research,” a journal of the American Association for Cancer Research.
